Expression of Her2 and drug efflux proteins in parental and resistant cell models. Expression of Her2 and drug efflux proteins in parental and resistant.

Slides:



Advertisements
Similar presentations
An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes.
Advertisements

HMGA2 is a SUMOylation target.
Expression of α5β1-integrin enhances EboV GP-mediated infection of GD25 cells. Expression of α5β1-integrin enhances EboV GP-mediated infection of GD25.
AKT dependence of ovarian cancer cell lines.
Predicting drug sensitivity and resistance
Protein microarrays for validation of antibodies.
NM-3 induces p21 levels and down-regulation of Cdk2 activity.
Overexpression of HGF decreases MET protein levels.
Role of HER2 in mediating acquired resistance to EGFR inhibition.
AML cells display differential sensitivity to inhibition of IKBKE and TBK1. AML cells display differential sensitivity to inhibition of IKBKE and TBK1.
High-affinity binding to the hypervariable region of the β1 I-like domain controls signaling to fibronectin fibrillogenesis. High-affinity binding to the.
Lapatinib reduces IGF-I signaling in trastuzumab-resistant cells.
Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.
Dissociation of HP1α from H3K9me3 is critical to potentiation of steady-state ATM activity. Dissociation of HP1α from H3K9me3 is critical to potentiation.
Decreased KATP activity for SUR1 (ABCC8) channels harboring R1420H or R1420C mutations. Decreased KATP activity for SUR1 (ABCC8) channels harboring R1420H.
Curcumin-generated ROS activates Chk1 and Chk2 kinases.
GA blocks HIF activity and reduces HIF target expression.
Immunohistochemical detection of 8-OHdG by use of the 1F7 monoclonal antibody in oligomer-treated PC3 prostate cancer cells. a, control untreated peripheral.
Representative Western blot analyses of S-phase and other proteins from PC3 cell lysates obtained 3 days after oligomer (400 nm)/Lipofectin (15 μg/ml)
Gramicidin A (GA) decreases HIF protein expression in RCC cells.
Variation in dUTPase expression in cell lines.
A, ATP production by PC3 prostate cancer cells after treatment with oligonucleotide/Lipofectin complexes. a, ATP production by PC3 prostate cancer cells.
Stimulatory effect induced by docetaxel, gefitinib, and cyclopamine on MMP (A) and (B) cytosolic cytochrome c level. Stimulatory effect induced by docetaxel,
A, cytotoxicity induced on HER2 3+ USC (ARK-2), HER2 0/1+ USC (ARK-4), and ARK-2/ARK-4 cocultures with 1 μg/mL of SYD985, T-DM1, and ADC isotype control.
Silencing hOGG1 triggers caspase-3 and caspase-7 activation in response to H2O2 in GM00637 cells. Silencing hOGG1 triggers caspase-3 and caspase-7 activation.
Identification of NSC as a FADD-kinase inhibitor.
Effect of LY on phosphorylation of various MAP kinase substrates in HeLa cells in vitro. Effect of LY on phosphorylation of various MAP kinase.
CARTmeso cell induction of antitumor antibodies.
Mapping the Pirh2 and p73 interaction sites.
CDDO-Me induces apoptosis independent of Bcl-2 level as well as p53 status in human NSCLC cells. CDDO-Me induces apoptosis independent of Bcl-2 level as.
Protein expression profile in a dasatinib-resistant cell line.
Flow cytometric analysis of T cell activation.
Mitotic catastrophe symptoms caused by curcumin are followed by apoptosis. Mitotic catastrophe symptoms caused by curcumin are followed by apoptosis. A.
Lamellarin D induces cell death through a Fas-independent pathway.
Down-regulation of the erbB-2 receptor by trastuzumab decreases Akt kinase activation but not MAPK activation. Down-regulation of the erbB-2 receptor by.
Flow cytometric analysis of single pMHCI-IgG binding and pMHCI delivery to hIGF-1R+ NIH3T3 and MCSP+ UCLA-SO-M14 cells target cells at different concentrations.
Effects of visfatin on the cell proliferation and phosphorylation of ERK, Akt, and GSK-3β proteins in HCC cells. Effects of visfatin on the cell proliferation.
Induction of cell death in prostate cancer cells by SAHA and ZOL
Expression of CRC stem cell markers and L1 in CRC cells.
ONC201 activates an ISR, decreases cyclin D1 expression, and causes an accumulation of cells in G1 in TNBC cells sensitive to the compounds' antiproliferative.
N87-TM model generation and characterization.
Curcumin suppresses the expression of antiapoptotic proteins in multiple myeloma cells. Curcumin suppresses the expression of antiapoptotic proteins in.
Gain-of-function conferred by RNF31 SNPs
KPT-9274 shows specificity for attenuation of PAK4 targets preferentially in RCC cells. KPT-9274 shows specificity for attenuation of PAK4 targets preferentially.
Immunohistochemical analysis of dUTPase in human breast adenocarcinoma
Activation of Wnt signaling pathway in trastuzumab-resistant cell lines. Activation of Wnt signaling pathway in trastuzumab-resistant cell lines. A, bar.
Role of MAPKs on DPP-23-induced autophagy and apoptosis.
Expression of XCR1 in normal ovarian surface epithelium and the IOSE and borderline EOC cell lines. Expression of XCR1 in normal ovarian surface epithelium.
Binding and antiproliferative effects of ANG4043 and anti-HER2 mAbs on tumor cells. Binding and antiproliferative effects of ANG4043 and anti-HER2 mAbs.
TET2 interacts with KLF1 transcription factor.
FACS analyses of the inhibitory effect induced by mixed docetaxel, gefitinib, and cyclopamine on EGF plus SHHNp–stimulated PC3 cells. FACS analyses of.
SY-1425 induces maturation in RARA-high AML
A, expression of p53 downstream mediator p21.
Changes in signal transduction pathway induced by gefitinib.
Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors. Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors.
A combination of neurotensin and insulin potently decreases YAP phosphorylation at Ser127 and Ser397 in PDAC cells. A combination of neurotensin and insulin.
2D-PAGE gels showing differentially expressed proteins in Panc-1 cells transfected with siNR4A1 and functional classification of the proteins. 2D-PAGE.
The combination of trastuzumab and SU11274 abrogate Akt phosphorylation. The combination of trastuzumab and SU11274 abrogate Akt phosphorylation. Serum-starved.
ODC protein expression in paired benign and cancer tissue obtained from patients with PCA. The protein expression was measured by immunoblot analysis in.
Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Expression.
The activity of MRP1-EYFP is analogous to wild-type MRP1.
BCR/ABL expression, tyrosine phosphorylation, and signaling in dasatinib- and imatinib-resistant cell lines and the ubiquitin inhibitor lactacystin modifies.
Induction of PARP cleavage (A) and activation of caspases (B) after treatment with a combination of TRAIL and cisplatin. Induction of PARP cleavage (A)
Double knockdown of HER2/EGFR abolishes HPSE nucleolar localization in 231BR3 cells. Double knockdown of HER2/EGFR abolishes HPSE nucleolar localization.
Expression and induction of HER2 and HPSE in 231BMBC cells.
Establishment of HeLa/rtTAA/TRE-N1-IC cell line.
RA-9 induces G2–M cell-cycle arrest and caspase-mediated apoptosis in ovarian cancer cells. RA-9 induces G2–M cell-cycle arrest and caspase-mediated apoptosis.
Depletion of murine Dnmt proteins after 5-Aza-CdR treatment.
RIL21 and checkpoint blockade restore IFNγ production in Tim-3+PD-1+ intratumoral NK cells from cancer patients. rIL21 and checkpoint blockade restore.
TCTP enhances the protein stability of Pim-3 by blocking the ubiquitin–proteasome degradation of Pim-3. TCTP enhances the protein stability of Pim-3 by.
Presentation transcript:

Expression of Her2 and drug efflux proteins in parental and resistant cell models. Expression of Her2 and drug efflux proteins in parental and resistant cell models. A, immunoblot analyses of 80 μg total protein from whole-cell lysates show Her2 levels decreased in JIMT1-TM cells and partially reduced in 361-TM cells. ABCC1 (MRP1) expression is elevated in 361-TM cells, but not in JIMT1-TM cells or in their parental counterparts. A549 and H69AR cells serve as positive controls for ABCC1. No detectable ABCB1 (MDR1) was observed in either 361-TM or JIMT1-TM cells, compared with positive controls KB-8.5 and KB-V1 cells. Cell lines were analyzed by flow cytometry for trastuzumab antibody binding (B) and internalization (C). 361, blue lines; JIMT1, red lines; parental cells, open symbols; TM-ADC–resistant cells, closed symbols. D, flow cytometric analysis of ABCC1 antibody shows elevated binding in 361-TM cells relative to parental 361 cells. Secondary antibody only (gray bar); 10 μg/mL ABCC1 antibody (blue bar). E, efflux study demonstrates increased accumulation of rhodamine in 361-TM cells compared with parental cells in the presence of reversan. *, P < 0.001 difference compared with 361 cells as evaluated by Student t test. Reference cell lines A549 and H69AR express ABCC1. Frank Loganzo et al. Mol Cancer Ther 2015;14:952-963 ©2015 by American Association for Cancer Research